Inactivation of the E-Prostanoid 3 Receptor Attenuates the Angiotensin II Pressor Response via Decreasing Arterial Contractility

被引:54
作者
Chen, Lihong [1 ,2 ]
Miao, Yifei [1 ,2 ]
Zhang, Yahua
Dou, Dou [1 ]
Liu, Limei [1 ]
Tian, Xiaoyu [4 ]
Yang, Guangrui [1 ,2 ]
Pu, Dan [1 ,2 ]
Zhang, Xiaoyan [1 ,2 ]
Kang, Jihong [1 ,2 ]
Gao, Yuansheng
Wang, Shigiang [5 ]
Breyer, Matthew D. [3 ]
Wang, Nanping [2 ]
Zhu, Yi [1 ,2 ,3 ]
Huang, Yu [4 ]
Breyer, Richard M. [3 ]
Guan, Youfei
机构
[1] Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing 100191, Peoples R China
[2] Minist Educ, Key Lab Cardiovasc Sci, Beijing, Peoples R China
[3] Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol & Hypertens, Nashville, TN USA
[4] Chinese Univ Hong Kong, Sch Biomed Sci, Li Ka Shing Inst Hlth Sci, Inst Vasc Med, Shatin, Hong Kong, Peoples R China
[5] Peking Univ, Inst Life Sci, Beijing 100191, Peoples R China
基金
美国国家卫生研究院;
关键词
angiotensin II; calcium; E-prostanoid; 3; hypertension; vasoconstriction; C-TERMINAL TAIL; BLOOD-PRESSURE; EP3; RECEPTOR; PROSTAGLANDIN RECEPTORS; MICE LACKING; SUBTYPE; EXPRESSION; HYPERTENSION; ISOFORMS; CALCIUM;
D O I
10.1161/ATVBAHA.112.254052
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-The present studies aimed a elucidating the role of prostaglandin E-2 receptor subtype 3 (E-prostanoid [EP] 3) in regulating blood pressure. Methods and Results-Mice bearing a genetic disruption of the EP3 gene (EP3-/-) exhibited reduced baseline mean arterial pressure monitored by both tail-cuff and carotid arterial catheterization. The pressor responses induced by EP3 agonists M&B28767 and sulprostone were markedly attenuated in EP3(-/-) mice, whereas the reduction of blood pressure induced by prostaglandin E-2 was comparable in both genotypes. Vasopressor effect of acme or chronic infusion of angiotensin II (Ang II) was attenuated in EP3(-/-) mice. Ang II-induced vasoconstriction in mesenteric arteries decreased in EP3(-/-) group. In mesenteric arteries from wild-type mice, Ang II-induced vasoconstriction was inhibited by EP3 selective antagonist DG-041 or L798106. The expression of Arhgef-1 is attenuated in EP3 deficient mesenteric arteries. EP3 antagonist DG-041 diminished Ang II-induced phosphorylation of myosin light chain 20 and myosin phosphatase target subunit 1 in isolated mesenteric arteries. Furthermore, in vascular smooth muscle cells, Ang II induced intracellular Ca2+ increase was potentiated by EP3 agonist sulprostone but inhibited by DG-041. Conclusion-Activation of the EP3 receptor raises baseline blood pressure and contributes to Ang II dependent hypertension a least partially via enhancing Ca2+ sensitivity and intracellular calcium concentration in vascular smooth muscle cells. Selective targeting of the EP3 receptor may represent a potential therapeutic target for the treatment of hypertension. (Arterioscler Thromb Vasc Biol. 2012;32:3024-3032.)
引用
收藏
页码:3024 / +
页数:22
相关论文
共 51 条
[1]   ISOFORMS OF THE EP3 SUBTYPE OF HUMAN PROSTAGLANDIN E(2) RECEPTOR TRANSDUCE BOTH INTRACELLULAR CALCIUM AND CAMP SIGNALS [J].
AN, SZ ;
YANG, JH ;
SO, SW ;
ZENG, L ;
GOETZL, EJ .
BIOCHEMISTRY, 1994, 33 (48) :14496-14502
[2]   Roles of the central prostaglandin EP3 receptors in cardiovascular regulation in rats [J].
Ariumi, H ;
Takano, Y ;
Masumi, A ;
Takahashi, S ;
Hirabara, Y ;
Honda, K ;
Saito, R ;
Kamiya, H .
NEUROSCIENCE LETTERS, 2002, 324 (01) :61-64
[3]   G protein-coupled prostanoid receptors and the kidney [J].
Bryer, MD ;
Breyer, RM .
ANNUAL REVIEW OF PHYSIOLOGY, 2001, 63 :579-605
[4]   Cyclooxygenases, the kidney, and hypertension [J].
Cheng, HF ;
Harris, RC .
HYPERTENSION, 2004, 43 (03) :525-530
[5]   A NOVEL INHIBITORY PROSTANOID RECEPTOR IN PIGLET SAPHENOUS-VEIN [J].
COLEMAN, RA ;
GRIX, SP ;
HEAD, SA ;
LOUTTIT, JB ;
MALLETT, A ;
SHELDRICK, RLG .
PROSTAGLANDINS, 1994, 47 (02) :151-168
[6]   Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system [J].
Crowley, SD ;
Gurley, SB ;
Oliverio, MI ;
Pazmino, AK ;
Griffiths, R ;
Flannery, PJ ;
Spurney, RF ;
Kim, HS ;
Smithies, O ;
Le, TH ;
Coffman, TM .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (04) :1092-1099
[7]   Role for thromboxane receptors in angiotensin-II-Induced hypertension [J].
Francois, H ;
Athirakul, K ;
Mao, L ;
Rockman, H ;
Coffman, TM .
HYPERTENSION, 2004, 43 (02) :364-369
[8]  
FUNK CD, 1993, J BIOL CHEM, V268, P26767
[9]   VASOPRESSIN (V1) RECEPTOR CHARACTERISTICS IN RAT AORTIC SMOOTH-MUSCLE CELLS [J].
GOPALAKRISHNAN, V ;
XU, YJ ;
SULAKHE, PV ;
TRIGGLE, CR ;
MCNEILL, JR .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (06) :H1927-H1936
[10]   Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting [J].
Guan, Youfei ;
Zhang, Yahua ;
Wu, Jing ;
Qi, Zhonghua ;
Yang, Guangrui ;
Dou, Dou ;
Gao, Yuansheng ;
Chen, Lihong ;
Zhang, Xiaoyan ;
Davis, Linda S. ;
Wei, Mingfeng ;
Fan, Xuefeng ;
Carmosino, Monica ;
Hao, Chuanming ;
Imig, John D. ;
Breyer, Richard M. ;
Breyer, Matthew D. .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (09) :2496-2505